nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Rivaroxaban—ABCB1—ovarian cancer	0.0117	1	CrCbGaD
Linezolid—MAOB—myometrium—ovarian cancer	0.00988	0.0741	CbGeAlD
Linezolid—MAOB—embryo—ovarian cancer	0.00951	0.0712	CbGeAlD
Linezolid—MAOA—myometrium—ovarian cancer	0.00843	0.0632	CbGeAlD
Linezolid—MAOA—embryo—ovarian cancer	0.00811	0.0608	CbGeAlD
Linezolid—MAOB—uterine cervix—ovarian cancer	0.00769	0.0576	CbGeAlD
Linezolid—MAOB—decidua—ovarian cancer	0.00733	0.0549	CbGeAlD
Linezolid—MAOB—endometrium—ovarian cancer	0.00696	0.0521	CbGeAlD
Linezolid—MAOA—uterine cervix—ovarian cancer	0.00656	0.0492	CbGeAlD
Linezolid—MAOB—uterus—ovarian cancer	0.00641	0.048	CbGeAlD
Linezolid—MAOA—decidua—ovarian cancer	0.00625	0.0469	CbGeAlD
Linezolid—MAOA—endometrium—ovarian cancer	0.00594	0.0445	CbGeAlD
Linezolid—MAOB—female reproductive system—ovarian cancer	0.00576	0.0432	CbGeAlD
Linezolid—MAOA—uterus—ovarian cancer	0.00547	0.041	CbGeAlD
Linezolid—MAOB—female gonad—ovarian cancer	0.00524	0.0393	CbGeAlD
Linezolid—MAOB—vagina—ovarian cancer	0.00521	0.0391	CbGeAlD
Linezolid—MAOA—female reproductive system—ovarian cancer	0.00492	0.0368	CbGeAlD
Linezolid—MAOB—testis—ovarian cancer	0.00465	0.0349	CbGeAlD
Linezolid—MAOA—female gonad—ovarian cancer	0.00447	0.0335	CbGeAlD
Linezolid—MAOA—vagina—ovarian cancer	0.00445	0.0333	CbGeAlD
Linezolid—MAOA—testis—ovarian cancer	0.00397	0.0297	CbGeAlD
Linezolid—MAOB—lymph node—ovarian cancer	0.00337	0.0253	CbGeAlD
Linezolid—MAOA—lymph node—ovarian cancer	0.00288	0.0216	CbGeAlD
Linezolid—Constipation—Vinorelbine—ovarian cancer	0.00114	0.00133	CcSEcCtD
Linezolid—Chills—Paclitaxel—ovarian cancer	0.00113	0.00133	CcSEcCtD
Linezolid—Phlebitis—Doxorubicin—ovarian cancer	0.00112	0.00131	CcSEcCtD
Linezolid—Asthenia—Topotecan—ovarian cancer	0.00112	0.00131	CcSEcCtD
Linezolid—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00112	0.0013	CcSEcCtD
Linezolid—Vomiting—Chlorambucil—ovarian cancer	0.00111	0.0013	CcSEcCtD
Linezolid—Pruritus—Topotecan—ovarian cancer	0.0011	0.00129	CcSEcCtD
Linezolid—Erythema—Paclitaxel—ovarian cancer	0.0011	0.00129	CcSEcCtD
Linezolid—Asthenia—Melphalan—ovarian cancer	0.0011	0.00128	CcSEcCtD
Linezolid—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00109	0.00128	CcSEcCtD
Linezolid—Flatulence—Paclitaxel—ovarian cancer	0.00108	0.00127	CcSEcCtD
Linezolid—Pruritus—Melphalan—ovarian cancer	0.00108	0.00126	CcSEcCtD
Linezolid—Dysgeusia—Paclitaxel—ovarian cancer	0.00108	0.00126	CcSEcCtD
Linezolid—Haemoglobin—Docetaxel—ovarian cancer	0.00108	0.00126	CcSEcCtD
Linezolid—Haemorrhage—Docetaxel—ovarian cancer	0.00107	0.00125	CcSEcCtD
Linezolid—Hypoglycaemia—Epirubicin—ovarian cancer	0.00107	0.00125	CcSEcCtD
Linezolid—Diarrhoea—Topotecan—ovarian cancer	0.00107	0.00125	CcSEcCtD
Linezolid—Hypoaesthesia—Docetaxel—ovarian cancer	0.00106	0.00125	CcSEcCtD
Linezolid—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.00106	0.00125	CcSEcCtD
Linezolid—Pharyngitis—Docetaxel—ovarian cancer	0.00106	0.00124	CcSEcCtD
Linezolid—Urticaria—Vinorelbine—ovarian cancer	0.00106	0.00124	CcSEcCtD
Linezolid—Muscle spasms—Paclitaxel—ovarian cancer	0.00106	0.00124	CcSEcCtD
Linezolid—Abdominal pain—Vinorelbine—ovarian cancer	0.00105	0.00123	CcSEcCtD
Linezolid—Body temperature increased—Vinorelbine—ovarian cancer	0.00105	0.00123	CcSEcCtD
Linezolid—Hyponatraemia—Epirubicin—ovarian cancer	0.00105	0.00123	CcSEcCtD
Linezolid—Diarrhoea—Melphalan—ovarian cancer	0.00104	0.00122	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.00104	0.00122	CcSEcCtD
Linezolid—Nausea—Chlorambucil—ovarian cancer	0.00104	0.00122	CcSEcCtD
Linezolid—Vision blurred—Paclitaxel—ovarian cancer	0.00104	0.00121	CcSEcCtD
Linezolid—Dizziness—Topotecan—ovarian cancer	0.00103	0.00121	CcSEcCtD
Linezolid—Anaemia—Paclitaxel—ovarian cancer	0.00102	0.00119	CcSEcCtD
Linezolid—Erythema multiforme—Docetaxel—ovarian cancer	0.00101	0.00118	CcSEcCtD
Linezolid—Angioedema—Paclitaxel—ovarian cancer	0.001	0.00117	CcSEcCtD
Linezolid—Vomiting—Topotecan—ovarian cancer	0.000991	0.00116	CcSEcCtD
Linezolid—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000989	0.00116	CcSEcCtD
Linezolid—Vertigo—Paclitaxel—ovarian cancer	0.000987	0.00115	CcSEcCtD
Linezolid—Leukopenia—Paclitaxel—ovarian cancer	0.000984	0.00115	CcSEcCtD
Linezolid—Rash—Topotecan—ovarian cancer	0.000983	0.00115	CcSEcCtD
Linezolid—Dermatitis—Topotecan—ovarian cancer	0.000982	0.00115	CcSEcCtD
Linezolid—Headache—Topotecan—ovarian cancer	0.000976	0.00114	CcSEcCtD
Linezolid—Vomiting—Melphalan—ovarian cancer	0.00097	0.00114	CcSEcCtD
Linezolid—Hyponatraemia—Doxorubicin—ovarian cancer	0.000969	0.00113	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000965	0.00113	CcSEcCtD
Linezolid—Liver function test abnormal—Epirubicin—ovarian cancer	0.000963	0.00113	CcSEcCtD
Linezolid—Rash—Melphalan—ovarian cancer	0.000962	0.00113	CcSEcCtD
Linezolid—Dermatitis—Melphalan—ovarian cancer	0.000961	0.00112	CcSEcCtD
Linezolid—Chills—Docetaxel—ovarian cancer	0.00096	0.00112	CcSEcCtD
Linezolid—Cough—Paclitaxel—ovarian cancer	0.000959	0.00112	CcSEcCtD
Linezolid—Asthenia—Vinorelbine—ovarian cancer	0.000957	0.00112	CcSEcCtD
Linezolid—Convulsion—Paclitaxel—ovarian cancer	0.000952	0.00111	CcSEcCtD
Linezolid—Hypokalaemia—Epirubicin—ovarian cancer	0.000949	0.00111	CcSEcCtD
Linezolid—Hypertension—Paclitaxel—ovarian cancer	0.000949	0.00111	CcSEcCtD
Linezolid—Pruritus—Vinorelbine—ovarian cancer	0.000943	0.0011	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000939	0.0011	CcSEcCtD
Linezolid—Erythema—Docetaxel—ovarian cancer	0.000931	0.00109	CcSEcCtD
Linezolid—Nausea—Topotecan—ovarian cancer	0.000926	0.00108	CcSEcCtD
Linezolid—Gastritis—Epirubicin—ovarian cancer	0.000923	0.00108	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00092	0.00108	CcSEcCtD
Linezolid—Dry mouth—Paclitaxel—ovarian cancer	0.000915	0.00107	CcSEcCtD
Linezolid—Diarrhoea—Vinorelbine—ovarian cancer	0.000912	0.00107	CcSEcCtD
Linezolid—Dysgeusia—Docetaxel—ovarian cancer	0.000912	0.00107	CcSEcCtD
Linezolid—Nausea—Melphalan—ovarian cancer	0.000907	0.00106	CcSEcCtD
Linezolid—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000897	0.00105	CcSEcCtD
Linezolid—Muscle spasms—Docetaxel—ovarian cancer	0.000896	0.00105	CcSEcCtD
Linezolid—Eosinophilia—Epirubicin—ovarian cancer	0.000893	0.00104	CcSEcCtD
Linezolid—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000891	0.00104	CcSEcCtD
Linezolid—Pancreatitis—Epirubicin—ovarian cancer	0.000884	0.00103	CcSEcCtD
Linezolid—Dizziness—Vinorelbine—ovarian cancer	0.000882	0.00103	CcSEcCtD
Linezolid—Hypokalaemia—Doxorubicin—ovarian cancer	0.000878	0.00103	CcSEcCtD
Linezolid—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000878	0.00103	CcSEcCtD
Linezolid—Skin disorder—Paclitaxel—ovarian cancer	0.000871	0.00102	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000869	0.00102	CcSEcCtD
Linezolid—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000867	0.00101	CcSEcCtD
Linezolid—Anaemia—Docetaxel—ovarian cancer	0.000861	0.00101	CcSEcCtD
Linezolid—Pancytopenia—Epirubicin—ovarian cancer	0.000856	0.001	CcSEcCtD
Linezolid—Anorexia—Paclitaxel—ovarian cancer	0.000855	0.001	CcSEcCtD
Linezolid—Gastritis—Doxorubicin—ovarian cancer	0.000854	0.000999	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000851	0.000996	CcSEcCtD
Linezolid—Vomiting—Vinorelbine—ovarian cancer	0.000848	0.000992	CcSEcCtD
Linezolid—Neutropenia—Epirubicin—ovarian cancer	0.000843	0.000986	CcSEcCtD
Linezolid—Rash—Vinorelbine—ovarian cancer	0.000841	0.000983	CcSEcCtD
Linezolid—Dermatitis—Vinorelbine—ovarian cancer	0.00084	0.000983	CcSEcCtD
Linezolid—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000838	0.00098	CcSEcCtD
Linezolid—Headache—Vinorelbine—ovarian cancer	0.000835	0.000977	CcSEcCtD
Linezolid—Leukopenia—Docetaxel—ovarian cancer	0.000834	0.000975	CcSEcCtD
Linezolid—Eosinophilia—Doxorubicin—ovarian cancer	0.000826	0.000966	CcSEcCtD
Linezolid—Pancreatitis—Doxorubicin—ovarian cancer	0.000818	0.000957	CcSEcCtD
Linezolid—Hyperglycaemia—Epirubicin—ovarian cancer	0.000813	0.000951	CcSEcCtD
Linezolid—Cough—Docetaxel—ovarian cancer	0.000813	0.000951	CcSEcCtD
Linezolid—Insomnia—Paclitaxel—ovarian cancer	0.000811	0.000949	CcSEcCtD
Linezolid—Pneumonia—Epirubicin—ovarian cancer	0.000809	0.000946	CcSEcCtD
Linezolid—Convulsion—Docetaxel—ovarian cancer	0.000807	0.000944	CcSEcCtD
Linezolid—Paraesthesia—Paclitaxel—ovarian cancer	0.000805	0.000942	CcSEcCtD
Linezolid—Hypertension—Docetaxel—ovarian cancer	0.000804	0.000941	CcSEcCtD
Linezolid—Dyspnoea—Paclitaxel—ovarian cancer	0.0008	0.000935	CcSEcCtD
Linezolid—Somnolence—Paclitaxel—ovarian cancer	0.000797	0.000933	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000797	0.000932	CcSEcCtD
Linezolid—Pancytopenia—Doxorubicin—ovarian cancer	0.000792	0.000927	CcSEcCtD
Linezolid—Nausea—Vinorelbine—ovarian cancer	0.000792	0.000927	CcSEcCtD
Linezolid—Renal failure—Epirubicin—ovarian cancer	0.00079	0.000924	CcSEcCtD
Linezolid—Dyspepsia—Paclitaxel—ovarian cancer	0.000789	0.000924	CcSEcCtD
Linezolid—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000788	0.000922	CcSEcCtD
Linezolid—Stomatitis—Epirubicin—ovarian cancer	0.000784	0.000917	CcSEcCtD
Linezolid—Neutropenia—Doxorubicin—ovarian cancer	0.00078	0.000913	CcSEcCtD
Linezolid—Decreased appetite—Paclitaxel—ovarian cancer	0.00078	0.000912	CcSEcCtD
Linezolid—Dry mouth—Docetaxel—ovarian cancer	0.000776	0.000907	CcSEcCtD
Linezolid—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000775	0.000907	CcSEcCtD
Linezolid—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000774	0.000906	CcSEcCtD
Linezolid—Fatigue—Paclitaxel—ovarian cancer	0.000773	0.000905	CcSEcCtD
Linezolid—Constipation—Paclitaxel—ovarian cancer	0.000767	0.000897	CcSEcCtD
Linezolid—Pain—Paclitaxel—ovarian cancer	0.000767	0.000897	CcSEcCtD
Linezolid—Anaphylactic shock—Docetaxel—ovarian cancer	0.00076	0.000889	CcSEcCtD
Linezolid—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000753	0.00088	CcSEcCtD
Linezolid—Pneumonia—Doxorubicin—ovarian cancer	0.000748	0.000875	CcSEcCtD
Linezolid—Thrombocytopenia—Docetaxel—ovarian cancer	0.000744	0.000871	CcSEcCtD
Linezolid—Skin disorder—Docetaxel—ovarian cancer	0.000738	0.000864	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000737	0.000863	CcSEcCtD
Linezolid—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000733	0.000858	CcSEcCtD
Linezolid—Renal failure—Doxorubicin—ovarian cancer	0.000731	0.000855	CcSEcCtD
Linezolid—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000729	0.000853	CcSEcCtD
Linezolid—Haemoglobin—Epirubicin—ovarian cancer	0.000725	0.000849	CcSEcCtD
Linezolid—Stomatitis—Doxorubicin—ovarian cancer	0.000725	0.000848	CcSEcCtD
Linezolid—Anorexia—Docetaxel—ovarian cancer	0.000725	0.000848	CcSEcCtD
Linezolid—Haemorrhage—Epirubicin—ovarian cancer	0.000722	0.000844	CcSEcCtD
Linezolid—Hypoaesthesia—Epirubicin—ovarian cancer	0.000718	0.00084	CcSEcCtD
Linezolid—Pharyngitis—Epirubicin—ovarian cancer	0.000716	0.000838	CcSEcCtD
Linezolid—Urticaria—Paclitaxel—ovarian cancer	0.000712	0.000833	CcSEcCtD
Linezolid—Abdominal pain—Paclitaxel—ovarian cancer	0.000709	0.000829	CcSEcCtD
Linezolid—Body temperature increased—Paclitaxel—ovarian cancer	0.000709	0.000829	CcSEcCtD
Linezolid—Insomnia—Docetaxel—ovarian cancer	0.000688	0.000804	CcSEcCtD
Linezolid—Paraesthesia—Docetaxel—ovarian cancer	0.000683	0.000799	CcSEcCtD
Linezolid—Erythema multiforme—Epirubicin—ovarian cancer	0.000682	0.000798	CcSEcCtD
Linezolid—Dyspnoea—Docetaxel—ovarian cancer	0.000678	0.000793	CcSEcCtD
Linezolid—Somnolence—Docetaxel—ovarian cancer	0.000676	0.000791	CcSEcCtD
Linezolid—Tinnitus—Epirubicin—ovarian cancer	0.000673	0.000787	CcSEcCtD
Linezolid—Haemoglobin—Doxorubicin—ovarian cancer	0.000671	0.000785	CcSEcCtD
Linezolid—Dyspepsia—Docetaxel—ovarian cancer	0.000669	0.000783	CcSEcCtD
Linezolid—Haemorrhage—Doxorubicin—ovarian cancer	0.000668	0.000781	CcSEcCtD
Linezolid—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000664	0.000777	CcSEcCtD
Linezolid—Pharyngitis—Doxorubicin—ovarian cancer	0.000663	0.000775	CcSEcCtD
Linezolid—Decreased appetite—Docetaxel—ovarian cancer	0.000661	0.000773	CcSEcCtD
Linezolid—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000656	0.000768	CcSEcCtD
Linezolid—Fatigue—Docetaxel—ovarian cancer	0.000655	0.000767	CcSEcCtD
Linezolid—Pain—Docetaxel—ovarian cancer	0.00065	0.00076	CcSEcCtD
Linezolid—Constipation—Docetaxel—ovarian cancer	0.00065	0.00076	CcSEcCtD
Linezolid—Chills—Epirubicin—ovarian cancer	0.000648	0.000758	CcSEcCtD
Linezolid—Asthenia—Paclitaxel—ovarian cancer	0.000643	0.000753	CcSEcCtD
Linezolid—Pruritus—Paclitaxel—ovarian cancer	0.000635	0.000742	CcSEcCtD
Linezolid—Erythema multiforme—Doxorubicin—ovarian cancer	0.000631	0.000739	CcSEcCtD
Linezolid—Erythema—Epirubicin—ovarian cancer	0.000628	0.000735	CcSEcCtD
Linezolid—Tinnitus—Doxorubicin—ovarian cancer	0.000623	0.000728	CcSEcCtD
Linezolid—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000622	0.000727	CcSEcCtD
Linezolid—Flatulence—Epirubicin—ovarian cancer	0.000619	0.000724	CcSEcCtD
Linezolid—Dysgeusia—Epirubicin—ovarian cancer	0.000615	0.00072	CcSEcCtD
Linezolid—Diarrhoea—Paclitaxel—ovarian cancer	0.000614	0.000718	CcSEcCtD
Linezolid—Muscle spasms—Epirubicin—ovarian cancer	0.000604	0.000707	CcSEcCtD
Linezolid—Abdominal pain—Docetaxel—ovarian cancer	0.000601	0.000703	CcSEcCtD
Linezolid—Body temperature increased—Docetaxel—ovarian cancer	0.000601	0.000703	CcSEcCtD
Linezolid—Chills—Doxorubicin—ovarian cancer	0.000599	0.000701	CcSEcCtD
Linezolid—Dizziness—Paclitaxel—ovarian cancer	0.000593	0.000694	CcSEcCtD
Linezolid—Vision blurred—Epirubicin—ovarian cancer	0.000592	0.000693	CcSEcCtD
Linezolid—Erythema—Doxorubicin—ovarian cancer	0.000581	0.00068	CcSEcCtD
Linezolid—Anaemia—Epirubicin—ovarian cancer	0.000581	0.000679	CcSEcCtD
Linezolid—Flatulence—Doxorubicin—ovarian cancer	0.000573	0.00067	CcSEcCtD
Linezolid—Vomiting—Paclitaxel—ovarian cancer	0.00057	0.000667	CcSEcCtD
Linezolid—Dysgeusia—Doxorubicin—ovarian cancer	0.000569	0.000666	CcSEcCtD
Linezolid—Rash—Paclitaxel—ovarian cancer	0.000565	0.000662	CcSEcCtD
Linezolid—Dermatitis—Paclitaxel—ovarian cancer	0.000565	0.000661	CcSEcCtD
Linezolid—Vertigo—Epirubicin—ovarian cancer	0.000564	0.00066	CcSEcCtD
Linezolid—Leukopenia—Epirubicin—ovarian cancer	0.000562	0.000658	CcSEcCtD
Linezolid—Headache—Paclitaxel—ovarian cancer	0.000562	0.000657	CcSEcCtD
Linezolid—Muscle spasms—Doxorubicin—ovarian cancer	0.000559	0.000654	CcSEcCtD
Linezolid—Cough—Epirubicin—ovarian cancer	0.000548	0.000641	CcSEcCtD
Linezolid—Vision blurred—Doxorubicin—ovarian cancer	0.000548	0.000641	CcSEcCtD
Linezolid—Asthenia—Docetaxel—ovarian cancer	0.000545	0.000638	CcSEcCtD
Linezolid—Convulsion—Epirubicin—ovarian cancer	0.000544	0.000637	CcSEcCtD
Linezolid—Hypertension—Epirubicin—ovarian cancer	0.000542	0.000635	CcSEcCtD
Linezolid—Pruritus—Docetaxel—ovarian cancer	0.000538	0.000629	CcSEcCtD
Linezolid—Anaemia—Doxorubicin—ovarian cancer	0.000537	0.000629	CcSEcCtD
Linezolid—Nausea—Paclitaxel—ovarian cancer	0.000533	0.000623	CcSEcCtD
Linezolid—Dry mouth—Epirubicin—ovarian cancer	0.000523	0.000612	CcSEcCtD
Linezolid—Vertigo—Doxorubicin—ovarian cancer	0.000522	0.000611	CcSEcCtD
Linezolid—Leukopenia—Doxorubicin—ovarian cancer	0.00052	0.000609	CcSEcCtD
Linezolid—Diarrhoea—Docetaxel—ovarian cancer	0.00052	0.000608	CcSEcCtD
Linezolid—Anaphylactic shock—Epirubicin—ovarian cancer	0.000513	0.0006	CcSEcCtD
Linezolid—Cough—Doxorubicin—ovarian cancer	0.000507	0.000593	CcSEcCtD
Linezolid—Convulsion—Doxorubicin—ovarian cancer	0.000504	0.000589	CcSEcCtD
Linezolid—Dizziness—Docetaxel—ovarian cancer	0.000503	0.000588	CcSEcCtD
Linezolid—Thrombocytopenia—Epirubicin—ovarian cancer	0.000502	0.000587	CcSEcCtD
Linezolid—Hypertension—Doxorubicin—ovarian cancer	0.000502	0.000587	CcSEcCtD
Linezolid—Skin disorder—Epirubicin—ovarian cancer	0.000498	0.000583	CcSEcCtD
Linezolid—Hyperhidrosis—Epirubicin—ovarian cancer	0.000496	0.00058	CcSEcCtD
Linezolid—Anorexia—Epirubicin—ovarian cancer	0.000489	0.000572	CcSEcCtD
Linezolid—Dry mouth—Doxorubicin—ovarian cancer	0.000484	0.000566	CcSEcCtD
Linezolid—Vomiting—Docetaxel—ovarian cancer	0.000483	0.000565	CcSEcCtD
Linezolid—Rash—Docetaxel—ovarian cancer	0.000479	0.000561	CcSEcCtD
Linezolid—Dermatitis—Docetaxel—ovarian cancer	0.000479	0.00056	CcSEcCtD
Linezolid—Headache—Docetaxel—ovarian cancer	0.000476	0.000557	CcSEcCtD
Linezolid—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000474	0.000555	CcSEcCtD
Linezolid—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000465	0.000543	CcSEcCtD
Linezolid—Insomnia—Epirubicin—ovarian cancer	0.000464	0.000543	CcSEcCtD
Linezolid—Skin disorder—Doxorubicin—ovarian cancer	0.000461	0.000539	CcSEcCtD
Linezolid—Paraesthesia—Epirubicin—ovarian cancer	0.00046	0.000539	CcSEcCtD
Linezolid—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000459	0.000537	CcSEcCtD
Linezolid—Dyspnoea—Epirubicin—ovarian cancer	0.000457	0.000535	CcSEcCtD
Linezolid—Somnolence—Epirubicin—ovarian cancer	0.000456	0.000533	CcSEcCtD
Linezolid—Anorexia—Doxorubicin—ovarian cancer	0.000452	0.000529	CcSEcCtD
Linezolid—Nausea—Docetaxel—ovarian cancer	0.000452	0.000528	CcSEcCtD
Linezolid—Dyspepsia—Epirubicin—ovarian cancer	0.000451	0.000528	CcSEcCtD
Linezolid—Decreased appetite—Epirubicin—ovarian cancer	0.000446	0.000521	CcSEcCtD
Linezolid—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000443	0.000518	CcSEcCtD
Linezolid—Fatigue—Epirubicin—ovarian cancer	0.000442	0.000517	CcSEcCtD
Linezolid—Constipation—Epirubicin—ovarian cancer	0.000438	0.000513	CcSEcCtD
Linezolid—Pain—Epirubicin—ovarian cancer	0.000438	0.000513	CcSEcCtD
Linezolid—Insomnia—Doxorubicin—ovarian cancer	0.000429	0.000502	CcSEcCtD
Linezolid—Paraesthesia—Doxorubicin—ovarian cancer	0.000426	0.000498	CcSEcCtD
Linezolid—Dyspnoea—Doxorubicin—ovarian cancer	0.000423	0.000495	CcSEcCtD
Linezolid—Somnolence—Doxorubicin—ovarian cancer	0.000422	0.000493	CcSEcCtD
Linezolid—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000419	0.00049	CcSEcCtD
Linezolid—Dyspepsia—Doxorubicin—ovarian cancer	0.000418	0.000489	CcSEcCtD
Linezolid—Decreased appetite—Doxorubicin—ovarian cancer	0.000412	0.000482	CcSEcCtD
Linezolid—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00041	0.000479	CcSEcCtD
Linezolid—Fatigue—Doxorubicin—ovarian cancer	0.000409	0.000478	CcSEcCtD
Linezolid—Urticaria—Epirubicin—ovarian cancer	0.000407	0.000477	CcSEcCtD
Linezolid—Pain—Doxorubicin—ovarian cancer	0.000406	0.000475	CcSEcCtD
Linezolid—Constipation—Doxorubicin—ovarian cancer	0.000406	0.000475	CcSEcCtD
Linezolid—Body temperature increased—Epirubicin—ovarian cancer	0.000405	0.000474	CcSEcCtD
Linezolid—Abdominal pain—Epirubicin—ovarian cancer	0.000405	0.000474	CcSEcCtD
Linezolid—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000388	0.000454	CcSEcCtD
Linezolid—Urticaria—Doxorubicin—ovarian cancer	0.000377	0.000441	CcSEcCtD
Linezolid—Abdominal pain—Doxorubicin—ovarian cancer	0.000375	0.000439	CcSEcCtD
Linezolid—Body temperature increased—Doxorubicin—ovarian cancer	0.000375	0.000439	CcSEcCtD
Linezolid—Asthenia—Epirubicin—ovarian cancer	0.000368	0.00043	CcSEcCtD
Linezolid—Pruritus—Epirubicin—ovarian cancer	0.000363	0.000424	CcSEcCtD
Linezolid—Diarrhoea—Epirubicin—ovarian cancer	0.000351	0.00041	CcSEcCtD
Linezolid—Asthenia—Doxorubicin—ovarian cancer	0.00034	0.000398	CcSEcCtD
Linezolid—Dizziness—Epirubicin—ovarian cancer	0.000339	0.000397	CcSEcCtD
Linezolid—Pruritus—Doxorubicin—ovarian cancer	0.000336	0.000393	CcSEcCtD
Linezolid—Vomiting—Epirubicin—ovarian cancer	0.000326	0.000381	CcSEcCtD
Linezolid—Diarrhoea—Doxorubicin—ovarian cancer	0.000325	0.00038	CcSEcCtD
Linezolid—Rash—Epirubicin—ovarian cancer	0.000323	0.000378	CcSEcCtD
Linezolid—Dermatitis—Epirubicin—ovarian cancer	0.000323	0.000378	CcSEcCtD
Linezolid—Headache—Epirubicin—ovarian cancer	0.000321	0.000376	CcSEcCtD
Linezolid—Dizziness—Doxorubicin—ovarian cancer	0.000314	0.000367	CcSEcCtD
Linezolid—Nausea—Epirubicin—ovarian cancer	0.000305	0.000356	CcSEcCtD
Linezolid—Vomiting—Doxorubicin—ovarian cancer	0.000302	0.000353	CcSEcCtD
Linezolid—Rash—Doxorubicin—ovarian cancer	0.000299	0.00035	CcSEcCtD
Linezolid—Dermatitis—Doxorubicin—ovarian cancer	0.000299	0.00035	CcSEcCtD
Linezolid—Headache—Doxorubicin—ovarian cancer	0.000297	0.000348	CcSEcCtD
Linezolid—Nausea—Doxorubicin—ovarian cancer	0.000282	0.00033	CcSEcCtD
